Literature DB >> 11855160

Retinal vein occlusion in two patients with primary antiphospholipid syndrome.

J K Kim1, M Y Kim, H S Yu, H K Jong, I S Hwang, C W Lee.   

Abstract

Primary antiphospholipid syndrome (APS) is a disease producing vascular thrombus with antiphospholipid antibody without association with autoimmune diseases as systemic lupus erythematosus. Retinal vein occlusion is a rare vascular manifestation in primary APS. We describe 2 cases of primary APS presenting with developing blurred vision. Each had central retinal vein occlusion and high titer of IgG anticardiolipin antibody.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11855160      PMCID: PMC4578058          DOI: 10.3904/kjim.2001.16.4.274

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  7 in total

Review 1.  Management of thrombosis in the antiphospholipid syndrome.

Authors:  M A Khamashta
Journal:  Lupus       Date:  1996-10       Impact factor: 2.911

2.  Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study.

Authors:  R Cobo-Soriano; S Sánchez-Ramón; M J Aparicio; M A Teijeiro; P Vidal; M Suárez-Leoz; M Rodriguez-Mahou; A Rodriguez-Huerta; E Fernández-Cruz; C Cortés
Journal:  Am J Ophthalmol       Date:  1999-12       Impact factor: 5.258

3.  Syndrome of the black swan.

Authors:  E N Harris
Journal:  Br J Rheumatol       Date:  1987-10

4.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

Authors:  R A Asherson; P Merry; J F Acheson; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

5.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

6.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

7.  Ocular vaso-occlusive disease in primary antiphospholipid syndrome.

Authors:  C Castañón; M C Amigo; J L Bañales; A Nava; P A Reyes
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

  7 in total
  1 in total

Review 1.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.